HeadlineShine

Dr Reddy’s Q2 profit falls 36%, plans semaglutide relaunch in November

MintDr Reddy’s Q2 profit falls 36%, plans semaglutide relaunch in November
Image: Mint

Lower US sales of generic Revlimid dragged down second-quarter earnings, but double-digit growth in base markets and the upcoming relaunch of semaglutide offer near-term relief.

Summary from Mint

Read the full story on Mint
React

Trending now

More top stories

See all →

Top stories in India

See all →